Press Releases and Media Coverage

2020-03/19
San Miguel County orders residents to shelter in place before countywide coronavirus testing
1
2019-11/26
United BioPharma Signs clinical trial agreement with NIH/NIAID for sponsorship of a multi-drug resistant HIV trial with UB-421
2
2019-11/08
United BioPharma Receives US FDA Approval for UB-221 Phase 1 IND for Chronic Spontaneous Urticaria
3
2019-10/23
In shocking reversal, Biogen to submit experimental Alzheimer’s drug for approval
4
2019-10/07
PharmaBoardRoom interview of Dr. Chang Yi Wang, Chairperson and Chief Scientific Officer of United Biopharma (UBP)
5
2019-09/25
UBI Asia announces IND acceptance by TFDA to conduct the first-in-human (FIH) phase-I trial in adults allergic rhinitis patients for UB-211, an UBITh® Allergy Immunotherapeutic Vaccine
6
2019-07/20
A vaccine for Alzheimer’s is on the verge of becoming a reality
7
2019-06/06
Is an Alzheimer’s Cure on the Horizon?
8
2019-06/11
United BioPharma Receives US FDA Approval for UB-621 Phase 2 Trial in Recurrent Genital Herpes Patients
9
2020-03/19
San Miguel County orders residents to shelter in place before countywide coronavirus testing
1
2019-11/26
United BioPharma Signs clinical trial agreement with NIH/NIAID for sponsorship of a multi-drug resistant HIV trial with UB-421
2
2019-11/08
United BioPharma Receives US FDA Approval for UB-221 Phase 1 IND for Chronic Spontaneous Urticaria
3
2019-10/23
In shocking reversal, Biogen to submit experimental Alzheimer’s drug for approval
4
2019-10/07
PharmaBoardRoom interview of Dr. Chang Yi Wang, Chairperson and Chief Scientific Officer of United Biopharma (UBP)
5
2019-09/25
UBI Asia announces IND acceptance by TFDA to conduct the first-in-human (FIH) phase-I trial in adults allergic rhinitis patients for UB-211, an UBITh® Allergy Immunotherapeutic Vaccine
6
2019-07/20
A vaccine for Alzheimer’s is on the verge of becoming a reality
7
2019-06/06
Is an Alzheimer’s Cure on the Horizon?
8
2019-06/11
United BioPharma Receives US FDA Approval for UB-621 Phase 2 Trial in Recurrent Genital Herpes Patients
9
Entered into a strategic partnership with IQUVIA, an international leading contract research organization (CRO) providing services in clinical trials 2017-03/10
United BioPharma won the Advanced Development of Innovative BioMalolecules award at the Asia-Pacific Bioprocessing Excellence Awards 2017 2017-02/25
President Dr. Mei-June Liao received the recognition for “Bioprocessing Executive of the year” at the 2017 Asia-Pacific Bioprocessing Excellence Forum 2017-02/24
The phase II data of UB-421 was presented at the late breaker session at CROI 2017 2017-02/15
Filed IND for UB-421 phase III clinical trial (HAART substitution) to TFDA 2017-01/15
Received certificate of occupancy for UBP’s eight-story (7000 sq Meter) headquarter building based in Huko, Hsinchu county designed for administrative, R&D and large scale protein drug manufacturing activities 2016-12/15
Filed IND for UB-921 (Anti-HER2 monoclonal antibody) phase I clinical trial to TFDA 2016-12/15
UBP entered into a licensing agreement with UBI US Holdings LLC and UBI IP Holdings, the subsidiary of United Biomedical, Inc (UBI) for exclusive US and ROW (ex-Asia) rights for development and commercialization of UB-421 2016-08/15
UB-421 for HIV treatment won the 12th National Innovation Prize given by Taiwan Biotechnology Strategic Planning Association 2015-12/15
IND submission of a phase I clinical trial for UB-621, an Anti-HSV-gD antibody, was approved by Taiwan Food and Drug Administration (TFDA) 2015-11/15